Benhadji KA et al. |
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells. |
2008 |
Br. J. Cancer |
pmid:19034280
|
|
|
|
|
pmid:19178487
|
|
|
|
|
pmid:19388934
|
Ghoul A et al. |
Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. |
2009 |
Cancer Res. |
pmid:19417139
|
|
|
|
|
pmid:19428919
|
|
|
|
|
pmid:19467365
|
|
|
|
|
pmid:19922462
|
Li L et al. |
The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. |
2010 |
Cancer Res. |
pmid:20460505
|
|
|
|
|
pmid:20467815
|
Lee WY et al. |
Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta. |
2010 |
J. Biol. Chem. |
pmid:20472553
|